Susquehanna International Group, LLP Vir Biotechnology, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 88,608 shares of VIR stock, worth $709,750. This represents 0.0% of its overall portfolio holdings.

Number of Shares

88,608

Previous 65,892 34.47%

Holding current value

$709,750

Previous $586,000 13.14%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.26 - $10.7 $164,918 - $243,061	22,716 Added 34.47%	88,608 $663,000
Q2 2024 Aug 15, 2024	SELL	$7.63 - $12.66 $190,574 - $316,208	-24,977 Reduced 27.49%	65,892 $586,000
Q1 2024 May 07, 2024	BUY	$8.6 - $11.9 $157,732 - $218,257	18,341 Added 25.29%	90,869 $920,000
Q4 2023 Feb 14, 2024	SELL	$7.76 - $10.29 $480,444 - $637,084	-61,913 Reduced 46.05%	72,528 $729,000
Q3 2023 Nov 14, 2023	BUY	$9.14 - $24.62 $755,676 - $2.04 Million	82,678 Added 159.72%	134,441 $1.26 Million
Q2 2023 Aug 11, 2023	SELL	$23.2 - $27.29 $2.57 Million - $3.03 Million	-110,892 Reduced 68.18%	51,763 $1.27 Million
Q1 2023 May 16, 2023	BUY	$22.26 - $30.85 $2.9 Million - $4.02 Million	130,249 Added 401.93%	162,655 $3.78 Million
Q4 2022 Feb 14, 2023	SELL	$19.96 - $28.22 $2.63 Million - $3.72 Million	-131,978 Reduced 80.29%	32,406 $820,000
Q3 2022 Nov 14, 2022	BUY	$18.26 - $31.1 $2.01 Million - $3.42 Million	109,865 Added 201.52%	164,384 $3.17 Million
Q2 2022 Aug 15, 2022	SELL	$19.08 - $26.7 $5.49 Million - $7.68 Million	-287,659 Reduced 84.07%	54,519 $1.39 Million
Q1 2022 May 16, 2022	BUY	$21.19 - $40.01 $3.2 Million - $6.05 Million	151,194 Added 79.17%	342,178 $8.8 Million
Q4 2021 Feb 14, 2022	BUY	$30.97 - $54.03 $1.03 Million - $1.79 Million	33,129 Added 20.99%	190,984 $8 Million
Q3 2021 Nov 15, 2021	BUY	$34.9 - $54.54 $2.07 Million - $3.23 Million	59,170 Added 59.96%	157,855 $6.87 Million
Q2 2021 Aug 11, 2021	BUY	$38.75 - $51.0 $3.27 Million - $4.31 Million	84,516 Added 596.49%	98,685 $4.67 Million
Q1 2021 May 17, 2021	SELL	$26.34 - $83.07 $1.54 Million - $4.85 Million	-58,391 Reduced 80.47%	14,169 $726,000
Q4 2020 Feb 16, 2021	BUY	$25.51 - $43.38 $507,087 - $862,307	19,878 Added 37.73%	72,560 $1.94 Million
Q3 2020 Nov 16, 2020	SELL	$28.28 - $53.6 $351,803 - $666,784	-12,440 Reduced 19.1%	52,682 $1.81 Million
Q2 2020 Aug 14, 2020	BUY	$27.89 - $47.86 $1.5 Million - $2.57 Million	53,605 Added 465.44%	65,122 $2.67 Million
Q1 2020 May 15, 2020	BUY	$12.04 - $60.2 $138,664 - $693,323	11,517 New	11,517 $395,000

Others Institutions Holding VIR

# of Institutions

220

Shares Held

87.4M

Call Options Held

127K

Put Options Held

1.19M

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.06B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Vir Biotechnology, Inc. Transaction History